The Global Virus Network: Challenging chikungunya
Author:
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference39 articles.
1. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection;Akahata;Nat. Med.,2010
2. An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors;Albulescu;J. Gen. Virol.,2014
3. Trigocherrierin A, a potent inhibitor of chikungunya virus replication;Bourjot;Molecules,2014
4. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus;Brandler;Vaccine,2013
5. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial;Chang;Lancet,2014
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Next-generation sequencing survey of acute febrile illness in Senegal (2020–2022);Frontiers in Microbiology;2024-04-09
2. Joint Involvement Can Predict Chikungunya in a Dengue Syndemic Setting in India;Journal of Epidemiology and Global Health;2023-11-14
3. Alterations in the Cellular Metabolic Footprint Induced by Mayaro Virus;BioMed;2023-02-24
4. Post-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh;Tropical Medicine and Health;2022-03-08
5. NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation;Journal of Virology;2021-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3